HLA-B40-, HLA-Cw3-, and HLA-DR5-associated susceptibility to amiodarone-induced thyroid dysfunction.
Erdoğan
M F
MF
Güleç
S
S
Tutar
E
E
Güldal
M
M
Başkal
N
N
Erdoğan
G
G
D000638:Amiodarone / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D006680:HLA Antigens; D015235:HLA-B Antigens; D059947:HLA-B40 Antigen; D015236:HLA-C Antigens; D015805:HLA-DR5 Antigen; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced / Q000276:immunology; D013959:Thyroid Diseases / Q000139:chemically induced* / Q000276:immunology*; D013971:Thyrotoxicosis / Q000139:chemically induced / Q000276:immunology
D000889:Anti-Arrhythmia Agents; D006680:HLA Antigens; D015235:HLA-B Antigens; D059947:HLA-B40 Antigen; D015236:HLA-C Antigens; C038653:HLA-C*03 antigen; D015805:HLA-DR5 Antigen; D000638:Amiodarone